Skip to main content

Tamoxifen class drugs reduce breast cancer rates by more than a third in women at high risk

Tamoxifen and three similar drugs reduce breast cancer incidence by 38 per cent in women at an increased risk of the disease according to a new study led by Queen Mary, University of London, published today in The Lancet.

Published on:
Back to top